logo

Novavax Inc. (NVAX)



Trade NVAX now with
  Date
  Headline
1/18/2023 8:02:13 AM Novavax : Nuvaxovid COVID-19 Vaccine Approved In South Korea As An Adult Booster
1/9/2023 9:03:25 AM Novavax Appoints John Jacobs As New President And CEO, Effective Jan.23
12/30/2022 8:02:55 AM Novavax Initiates Phase 2 Trial For COVID-19-Influenza Combination And Stand-Alone Influenza Vaccine Candidates
12/16/2022 12:23:21 AM Novavax Announces Pricing Of An Offering Of $150 Mln Of Its 5.00% Convertible Senior Notes Due 2027
12/16/2022 12:18:56 AM Novavax Announces Pricing Of $150 Mln Offering Of 5.00% Convertible Senior Notes Due 2027
12/7/2022 9:28:02 AM Novavax : Nuvaxovid COVID-19 Vaccine Approved In Canada For Use As Primary Series In Adolescents
11/29/2022 8:55:57 AM Novavax : WHO Issues Updated Emergency Use Listing For Nuvaxovid COVID-19 Vaccine
11/18/2022 8:15:47 AM Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization In Canada As Booster In Adults
11/9/2022 9:32:04 AM Novavax Nuvaxovid COVID-19 Vaccine Authorized In U.K For Use As Booster In Adults